ABL1 and acute lymphoblastic leukemia: Transcription of this fusion gene results in constitutively active p210 or p190 BCR-ABL tyrosine kinase [2], which is detected in 95% of CML and in 20-30% of adult acute lymphoblastic leukemia (ALL), respectively [3,4].